Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | KDM6B | O15054 | 1/20 | 0.41 |
| ▸ | KDM5C | P41229 | 1/20 | 0.41 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.41 |
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.36 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.35 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetoacetic Acid SCHEMBL29155554 | 1.00 | LMNA (0.45) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL491497 | 1.00 | LMNA (0.45) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL648595 | 1.00 | LMNA (0.45) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL5795622 | 0.89 | TGFBR1 (0.40) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Glycerin SCHEMBL28122415 | 0.89 | KDM4E (0.46) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL2005043 | 0.89 | KDM4E (0.37) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Glycerin SCHEMBL28686701 | 0.87 | ALDH1A1 (0.53) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL27153879 | 0.87 | THRB (0.54) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL28640192 | 0.85 | TDP1 (0.50) | LMNAALDH1A1KDM4EKDM6BKDM5C | |
| Acetoacetic Acid SCHEMBL1058961 | 0.85 | TDP1 (0.50) | LMNAALDH1A1KDM4EKDM6BKDM5C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4574871-A1 | CURABLE POLYMER COMPOSITIONS COMPRISING ALDIMINES, POLYISOCYANATES AND COMPOUNDS WITH ACTIVATED METHYLENE GROUPS | Sika Technology AG (CH) | 2025-06-25 | — | — | EP | claimed |
| EP-4574867-A1 | CURABLE POLYMER COMPOSITIONS CONTAINING ISOCYANATES, ALDIMINES AND COMPOUNDS HAVING ACTIVATED METHYLENE GROUPS | Sika Technology AG (CH) | 2025-06-25 | — | — | EP | claimed |
| US-5420335-A | Intravenous feeding | BIRKHAHN RONALD H (US) | 1995-05-30 | — | — | US | claimed |
| WO-1995009146-A1 | PARENTERAL NUTRIENTS BASED ON WATER SOLUBLE GLYCEROL BISACETOACETATES | EASTMAN CHEMICAL COMPANY (US) | 1995-04-06 | — | — | WO | claimed |
| US-12622967-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | TODAY, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4574871-A1 | CURABLE POLYMER COMPOSITIONS COMPRISING ALDIMINES, POLYISOCYANATES AND COMPOUNDS WITH ACTIVATED METHYLENE GROUPS | Sika Technology AG (CH) | 2025-06-25 | — | — | EP | disclosed |
| EP-4574867-A1 | CURABLE POLYMER COMPOSITIONS CONTAINING ISOCYANATES, ALDIMINES AND COMPOUNDS HAVING ACTIVATED METHYLENE GROUPS | Sika Technology AG (CH) | 2025-06-25 | — | — | EP | disclosed |
| US-20240299548-A1 | MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS | TODAY, INC. (US) | 2024-09-12 | — | — | US | disclosed |
| US-12071498-B2 | Radically polymerizable compositions | Polynt Composites USA, Inc. (US) | 2024-08-27 | — | — | US | disclosed |
| US-12023382-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | Today Inc. (US) | 2024-07-02 | — | — | US | disclosed |
| CN-113474383-B | Free radical polymerizable composition | 波林复合材料美国股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| US-20230257500-A1 | RADICALLY POLYMERIZABLE COMPOSITIONS | BNY MELLON CORPORATE TRUSTEE SERVICES LIMITED, AS SECURITY AGENT (GB) | 2023-08-17 | — | — | US | disclosed |
| EP-1749845-A1 | Composite materials and methods of making the same | Rohm and Haas Company (US) | 2007-02-07 | — | — | EP | disclosed |
| US-5693850-A | REACTING SOLKETAL AND AN ACETOACETATE ESTER OR PRECURSOR TO PRODUCE AN INTERMEDIATE SOLKETAL ACETOACETATE DERIVATIVE AND REDUCING IN PRESENCE OF HYDROGEN AND HYDROGENATION CATALYST TO FORM SOLKETAL-BETA-HYDROXYBUTYRATE; PARENTERAL DIET | EASTMAN CHEMICAL COMPANY (US) | 1997-12-02 | — | — | US | disclosed |
| US-5420335-A | Intravenous feeding | BIRKHAHN RONALD H (US) | 1995-05-30 | — | — | US | disclosed |
| US-5420335-A | Intravenous feeding | BIRKHAHN RONALD H (US) | 1995-05-30 | — | — | US | disclosed |
| US-5420335-A | Intravenous feeding | BIRKHAHN RONALD H (US) | 1995-05-30 | — | — | US | disclosed |
| WO-1995009144-A1 | NUTRITIVE WATER SOLUBLE GLYCEROL ESTERS OF HYDROXY BUTYRIC ACID | EASTMAN CHEMICAL COMPANY (US) | 1995-04-06 | — | — | WO | disclosed |
| WO-1995009146-A1 | PARENTERAL NUTRIENTS BASED ON WATER SOLUBLE GLYCEROL BISACETOACETATES | EASTMAN CHEMICAL COMPANY (US) | 1995-04-06 | — | — | WO | disclosed |
| WO-1995009146-A1 | PARENTERAL NUTRIENTS BASED ON WATER SOLUBLE GLYCEROL BISACETOACETATES | EASTMAN CHEMICAL COMPANY (US) | 1995-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622967-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | SLC2A9, GYS1, SLC2A8 | LMNA 3333/4885ALDH1A1 350/4885KDM4E 1504/4885 |
| US-20240299548-A1 | MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS | CPT1B, GK, CPT1A | LMNA 1973/4885ALDH1A1 1249/4885KDM4E 3282/4885 |
| US-12023382-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | CPT1B, GK, CPT1A | LMNA 1973/4885ALDH1A1 1249/4885KDM4E 3282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.